Memorial Sloan Kettering Cancer Center — New York, New York

Public research footprint of Memorial Sloan Kettering Cancer Center, compiled from the ClinicalTrials.gov public registry.

4,657

Registered studies

1,614

Active

783

Recruiting now

2,450

Completed

497

Stopped or withdrawn

Most-studied conditions

PDAC - Pancreatic Ductal Adenocarcinoma · Acute Respiratory Distress Syndrome (ARDS) · Acute Myeloid Leukemia · Pancreatic Cancer

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT06954337 — MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Memorial Sloan Kettering Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.